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F. Biancari,1* P. Romsi,1 J. Pera¨la¨,2 V. Koivukangas,1 R. Cresti1 and T. Juvonen1Departments of 1Surgery, and 2Radiology, Oulu University Hospital, P.O. Box 21, 90229 Oulu, FinlandSecondary aortoenteric fistula is a dramatic, rather infrequent late complication occurring mostly after abdominal aortic
surgery. Currently, graft excision and in situ bypass is considered the treatment of choice, but it is associated with
significant mortality and morbidity. Herein, we describe the case of a secondary aortoduodenal fistula treated by staged
endovascular stent-grafting and surgical closure of the fistula. Forty days after stent-grafting, Tc-99m-HMPAO labelled
leukocyte scanning failed to identify leukocyte infiltration of the graft and there were no clinical signs of infection. At 8-
month follow up, the patient was asymptomatic.Keywords: Secondary aorto-duodenal fistula; Endovascular; Stent-graft; Prosthesis infection.Introduction
Secondary aortoduodenal fistula is a dramatic, but
rather infrequent late complication of abdominal
aortic surgery. When left untreated, it is invariably
fatal and operative treatment is associated with high
mortality and morbidity. Staged extra-anatomic
bypass grafting followed by aortic graft excision;
graft excision and in situ bypass with allograft;
antibiotic impregnated prosthesis; silver-coated pros-
thesis or autogenous vein are current surgical treat-
ment options.
Recently, there have been a few reports of the
successful treatment of secondary aortoenteric fistulas
with endovascular stent-grafting.1–4 Late failures due
to recurrent infection have been described.5,6 Herein,
we describe a case of secondary aortoduodenal fistula
treated by staged endovascular stent-grafting and
surgical closure of the fistula.ing author. Fausto Biancari, MD, PhD, Division of
cic and Vascular Surgery, Department of Surgery, Oulu
ospital, Kajaanintie 50, PL 21, 90029 Oulu, Finland.
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A 58-year-old man was admitted because of
hematemesis and melena. Nine years previously,
he had undergone aortobifemoral bypass surgery
for aortoiliac occlusive disease. Two years pre-
viously he was admitted to our Institution because
of fever and pain in the right inguinal region. On
that occasion an abdominal ultrasound examination
was negative and the patient was treated conserva-
tively with oral antibiotics. Four weeks prior to
admission, he was admitted in a foreign hospital
because of gastrointestinal bleeding. At upper
gastrointestinal endoscopy, a gastric ulcer was
found and at colonoscopy diverticulae and polyps
were also found. On arrival, the patient did no
complain of abdominal symptoms and systolic
pressure was 90–100 mmHg. Hemoglobin concen-
tration was 92 g/L, C-reactive protein 8 mg/L and
leukocyte count 14.700/dL. The day after haemo-
globin concentration decreased to 83 g/L and red
blood cells were transfused. At upper gastrointesti-
nal endoscopy, an ulcer of the third portion of the
duodenum was observed, and computed tomogra-
phy showed in the posterior wall of the same
portion of the duodenum, in close contact withEur J Vasc Endovasc Surg 31, 42–43 (2006)
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Fig. 1. Computed tomography scans showing the Gore TAG stent-graft in place 12 days after surgical closure of the
aortoduodenal fistula.
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its left side an air collection of 1.8!0.8!1.1 cm.
Seven days after admission, a Gore TAG 2.6!10 cm
stent-graft (W. L. Gore and Associates, Inc., Flag-
staff, Arizona, USA) was successfully deployed into
the proximal aortic anastomosis segment (Fig. 1).
The day after, at laparotomy, the duodenal perfor-
ation was found, its margins resected, and the
resulted defect sutured in two layers. An anasto-
motic dehiscence completely sealed by the stent-
graft was found and sutured with polypropylene
stitches. Omentum was sutured in place. A jejunal
feeding tube was inserted into the jejunum 40 cm
from the duodenal suture. No macroscopic signs of
infection were detected in the fistula area, but on
bacterial culture of surgical specimens Enterobacter
cloacae grew. Postoperatively, piperacillin-tazobac-
tam, vancomycin and fluconazole were adminis-
tered. Thirteen days after laparotomy, a computed
tomography scan showed a small fluid collection in
front of the third part of the duodenum, and no
signs of perigraft endoleak was observed. C-reactive
protein increased up to 259 mg/L and slowly
decreased toward normal levels. Recovery was
uneventful and the patient was discharged on the
20th postoperative day and received ciprofloxacin
750 mg p.o. twice a day for 3 weeks. Forty days
after stent-grafting a Tc-99m-HMPAO labelled leu-
kocyte scan did not show any sign of leukocyte
collection. At 3-month follow up, the patient was
asymptomatic and computed tomographic angiogra-
phy showed a well-positioned stent-graft without
either fluid collection or any other signs of intra-
abdominal infection. Eight months after surgery the
patient was asymptomatic.Discussion
The present report confirms that endovascular stent-
grafting can be safely employed in the management of
aortoenteric fistulas. However, it remains unclear
whether this treatment represents a definitive pro-
cedure for this condition. We believe that lack of
treatment of the fistula, i.e. surgical closure of the
duodenal defect, could leave the patient exposed to
the risk of recurrent infection as has been reported
previously.1,6 In conclusion, staged endovascular and
surgical treatment of secondary aortoduodenal fistula
when no signs of graft infection exist, is a safe and
valuable treatment method. Long-term follow-up will
prove whether this is a durable procedure.References
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